Formulation and Drug Delivery, Biologic Drugs

Novo Nordisk Expands Research Collaboration in Novel Delivery Technologies for Biologic Medicines

March 10, 2022

Novo Nordisk will expand its existing research collaboration in novel delivery technologies with MIT and Brigham and Women’s Hospital.

Pfizer and Acuitas Therapeutics Collaborate on Lipid Nanoparticle Delivery System

January 11, 2022

The agreement expands Pfizer’s access to LNP formulation technology for mRNA vaccines and therapeutics.

Fujifilm Irvine Scientific Builds Bioprocessing Innovation and Collaboration Center in China

December 03, 2021

Fujifilm’s center adds local support in Suzhou, China for cell culture media optimization.

Lilly Forms Pact with Diabetes Tech Companies to Integrate Connected Insulin Pen Solutions

May 07, 2021

Eli Lilly and Company has partnered with leading diabetes tech firms to offer app compatibility with insulin smart pens to streamline diabetes management with automated data collection.

Overcoming Vaccine Development Challenges

May 03, 2021

Vaccine development is inherently challenging; however, in light of the COVID-19 pandemic, innovations have been prioritized, leading to accelerated development processes.

Evolving Analytical Technology Unravels Protein Characteristics

May 02, 2021

Mass spectrometry and automation are growing in importance for protein characterization, but further improvements are still needed.

Focusing on Accelerated Formulation Strategies

April 03, 2021

Accelerated formulation strategies are a useful tool to reduce development timelines and cost, but key priorities must be considered early on to ensure success.

CordenPharma Expands Lipid Supply for Moderna

June 04, 2020

CordenPharma announces expansion of lipid excipients supply for coronavirus vaccine scale up.

PharmTech Sponsored eBooks

Minimizing Contamination During BioPharm R&D

June 01, 2020

The right approach to biological safety cabinets, and collaboration between engineers and those who will operate the equipment, is crucial to preventing cell-culture contamination.

Orgenesis to Acquire Tamir Biotechnology for Broad Spectrum Antiviral Platform

April 14, 2020

With the acquisition, Orgenesis will combine TamirBio’s ranpirnase antiviral platform with its Bioxome technology.